GlassScriptPhysician profile
Moises Roizental
NPI 1568899896
$11,665.27
in general payments reported to CMS, 2019-2025
13 companies · $10K in 2025
The $10K reported for 2025 was more than what 89% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $132 · 2021: $215 · 2022: $101 · 2023: $109 · 2024: $759 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,130 · Debt Forgiveness: $2,624 · Consulting Fee: $1,500 · Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,130.36 |
| Debt Forgiveness | $2,623.71 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $655.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guerbet LLC | $7,659.16 | 2025 | Lipiodol |
| Merit Medical Systems INC | $2,623.71 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $457.40 | 2019-2025 | Venovo, Venclose Maven Catheter |
| Asahi Intecc USA, INC. | $357.91 | 2025 | Asahi Peripheral Vascular Wires, Asahi Interventional Radiology Wires |
| Boston Scientific Corporation | $225.85 | 2020-2023 | Varithena Administration Pack |
| Philips North America LLC | $96.71 | 2019 | |
| Medtronic, INC. | $76.28 | 2023-2024 | Kyphon Express II Kyphopak Tray, Ellipsys Vascular Access System |
| Siemens Medical Solutions USA, INC. | $43.82 | 2025 | Cios Alpha |
| Becton, Dickinson and Company | $39.69 | 2023 | Venclose Maven Catheter |
| Medtronic Vascular, INC. | $32.40 | 2019 | |
| Cardiva Medical, INC. | $23.06 | 2024 | Cardiva Vascade 6/7f Vcs |
| Smith+Nephew, INC. | $15.42 | 2019 | |
| Biocompatibles, INC. | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moises Roizental listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.